Mobilization of hematopoietic stem cells

被引:54
作者
Fu, S [1 ]
Liesveld, J [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Internal Med, Hematol Oncol Blood & Marrow Transplant Program, Rochester, NY 14642 USA
关键词
D O I
10.1054/blre.2000.0138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematopoietic stem cell transplantation has been extensively exploited as a therapeutic and research modality and has revolutionized current patient care. At present, more and more medical centers use peripheral blood progenitor cells for transplantation by mobilizing hematopoietic stem cells from bone marrow to peripheral blood because of potential advantages of peripheral blood stem cell transplantation over bone-marrow transplantation. Different effective mobilization regimens have been developed recently with chemotherapeutic agents, hematopoietic growth factors or their combination. This article reviews current developments related to hematopoietic stem cell mobilization including the biology of hematopoietic stem cells, strategies for mobilization, management for mobilization failure, mechanisms of mobilization, and side effects during mobilization. Finally the Initiation-Amplification-Emigration-Adaptation Model is proposed to help aid understanding of the mechanisms of hematopoietic stem cell mobilization and to stimulate development of novel and optimal mobilization strategies for patient care. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:205 / 218
页数:14
相关论文
共 136 条
  • [31] Innovations in allogeneic stem-cell transplantation
    DiPersio, JF
    Khoury, H
    Haug, J
    Vij, R
    Adkins, DR
    Goodnough, LT
    Brown, RA
    [J]. SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 33 - 41
  • [32] Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients:: A randomized, controlled trial
    Facon, T
    Harousseau, JL
    Maloisel, F
    Attal, M
    Odriozola, J
    Alegre, A
    Schroyens, W
    Hulin, C
    Schots, R
    Marin, P
    Guilhot, F
    Granena, A
    De Waele, M
    Pigneux, A
    Méresse, V
    Clark, P
    Reiffers, J
    [J]. BLOOD, 1999, 94 (04) : 1218 - 1225
  • [33] Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor
    Falzetti, F
    Aversa, F
    Minelli, O
    Tabilio, A
    [J]. LANCET, 1999, 353 (9152) : 555 - 555
  • [34] FIBBE WE, 2000, SEMI HEMATOL S2, V237, P189
  • [35] Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied
    Fischer, T
    Neubauer, A
    Mohm, J
    Huhn, D
    Busemann, C
    Link, H
    Arseniev, L
    Büssing, B
    Novotny, J
    Ganser, A
    Duyster, J
    Bunjes, D
    Westermeier, T
    Flohr, T
    Desprès, D
    Gamm, H
    Decker, J
    Derigs, G
    Aulitzky, W
    Huber, C
    [J]. ANNALS OF HEMATOLOGY, 1998, 77 (1-2) : 21 - 26
  • [36] G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability
    Fischmeister, G
    Kurz, M
    Haas, OA
    Micksche, M
    Buchinger, P
    Printz, D
    Ressmann, G
    Stroebel, T
    Peters, C
    Fritsch, G
    Gadner, H
    [J]. ANNALS OF HEMATOLOGY, 1999, 78 (03) : 117 - 123
  • [37] Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone
    Franklin, WA
    Glaspy, J
    Pflaumer, SM
    Jones, RB
    Hami, L
    Martinez, C
    Murphy, JR
    Shpall, EJ
    [J]. BLOOD, 1999, 94 (01) : 340 - 347
  • [38] The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients
    Gandhi, MK
    Jestice, K
    Scott, MA
    Bloxham, D
    Bass, G
    Marcus, RE
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (01) : 9 - 13
  • [39] Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy
    Glaspy, JA
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (Suppl 2) : S21 - S27
  • [40] Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients
    Glaspy, JA
    Shpall, EJ
    LeMaistre, CF
    Briddell, RA
    Menchaca, DM
    Turner, SA
    Lill, M
    Chap, L
    Jones, R
    Wiers, MD
    Sheridan, WP
    McNiece, IK
    [J]. BLOOD, 1997, 90 (08) : 2939 - 2951